OPKO Health, Inc. (NASDAQ:OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the ...

In this article, we will look at the 13 Best Long-Term Penny Stocks to Buy According to Analysts. What are the Fed’s Plans for 2025? On June 18, Société Générale’s Subadra Rajappa appeared on CNBC to ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

Strategic Agreements: OPKO Health has been active on multiple strategic fronts. In March, the company partnered with Entera Bio to develop a once-daily oral GLP-1/glucagon dual agonist tablet ...

Weston, Massachusetts Wednesday, June 11, 2025, 12:00 Hrs [IST] ...

WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the creation of a Scientific Advisory Board to provide counsel and ...

Accelerated Clinical Trials Buoys Optimism: OPKO Health has undertaken various trials and has been part of many with respect to its products. On the earnings call of third-quarter 2024, OPKO Health’s ...

OPKO Health bought ModeX in 2022 for its immunotherapy tech, with a focus on oncology and infectious diseases. At present, we cannot recommend OPKO stock to retail value investors.

Shares of Opko Health have decreased by 27.39% in the past year. An investor who bought shares of Opko Health at the beginning of the year would take a loss of $0.03 per share if they sold it today.

Healthcare company OPKO Health Inc has agreed to pay $10 million to resolve allegations that a unit that provides laboratory services rented office space from doctors at above-market rates so the ...